Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA071725-01
Application #
2010145
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1996-09-30
Project End
2000-07-31
Budget Start
1996-09-30
Budget End
1997-07-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Stanford University
Department
Pathology
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305

  Publications

Merad, Miriam; Sugie, Tomoharu; Engleman, Edgar G et al. (2002) In vivo manipulation of dendritic cells to induce therapeutic immunity. Blood 99:1676-82
Fong, L; Brockstedt, D; Benike, C et al. (2001) Dendritic cells injected via different routes induce immunity in cancer patients. J Immunol 166:4254-9
Fong, L; Brockstedt, D; Benike, C et al. (2001) Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy. J Immunol 167:7150-6
Merad, M; Fong, L; Bogenberger, J et al. (2000) Differentiation of myeloid dendritic cells into CD8alpha-positive dendritic cells in vivo. Blood 96:1865-72
Brockstedt, D G; Podsakoff, G M; Fong, L et al. (1999) Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clin Immunol 92:67-75
Engleman, E G (1997) Dendritic cells: potential role in cancer therapy. Cytotechnology 25:1-8
Fong, L; Ruegg, C L; Brockstedt, D et al. (1997) Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer. J Immunol 159:3113-7